Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant
- PMID: 30958549
- PMCID: PMC6460429
- DOI: 10.1093/asj/sjz054
Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant
Erratum in
-
Corrigendum to: Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant.Aesthet Surg J. 2021 Aug 13;41(9):1106. doi: 10.1093/asj/sjz125. Aesthet Surg J. 2021. PMID: 31067295 Free PMC article. No abstract available.
Abstract
Background: Although general guidelines are available for established silicone gel breast implants, the unique characteristics of the latest Motiva implants warrant specific guidelines.
Objectives: This study aimed to generate consensus recommendations and summarize expert-based advice to better understand current surgical practices and to establish guidelines for surgeons transitioning from other implant devices to the Motiva implants.
Methods: A survey was compiled by 12 plastic surgeon experts in aesthetic and reconstructive breast surgery and 1 biotechnology scientist, and distributed to 36 plastic surgeons to establish a consensus on the use of these devices. Surgical techniques, complication rates, and implant selection were among the topics discussed.
Results: The experts agreed on 3 core principles regarding the use of Motiva Round and Ergonomix implants. Firstly, the dissected pocket needs to be close fitting and steps must be taken to prevent expansion of the pocket. Secondly, implant selection must be individualized. Finally, surgical planning and technique must be carefully considered. When questioned about problems they had ecountered, 84.6% of the experts agreed that they experienced fewer overall complications and 76.9% confirmed reduced capsular contracture rates with these devices. Overall, 84.6% of the experts favored selecting Motiva Ergonomix implants over Round implants to achieve a more natural look. In addition, 92.3% of the experts agreed that Motiva implants, due to their innovative technology, reduce the risk of anaplastic large-cell lymphoma.
Conclusions: This international consensus of leading practitioners will assist plastic surgeons with patient selection, preoperative planning, and surgical technique. These recommendations are designed to optimize surgical outcomes, resulting in lower overall complication rates, more natural-looking breasts, and highly satisfied patients.
© 2019 The American Society for Aesthetic Plastic Surgery, Inc.
Figures






Comment in
-
Response to "Clarification About 'Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant'".Aesthet Surg J. 2019 Nov 13;39(12):NP540-NP542. doi: 10.1093/asj/sjz235. Aesthet Surg J. 2019. PMID: 31617876 Free PMC article. No abstract available.
-
Clarification About "Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant".Aesthet Surg J. 2019 Nov 13;39(12):NP538-NP539. doi: 10.1093/asj/sjz176. Aesthet Surg J. 2019. PMID: 31617890 No abstract available.
References
-
- Wolfram D, Dolores W, Rainer C, et al. . Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmun. 2004;23(1):81-91. - PubMed
-
- Kadin ME, Epstein AL, Adams W, et al. . Evidence that some breast implant associated anaplastic large cell lymphomas arise in the context of allergic inflammation. Blood. 2017;130(Suppl 1):4030.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical